Log in

OTCMKTS:PRLX - Parallax Health Sciences Stock Price, Forecast & News

0.00 (0.00 %)
(As of 02/21/2020 04:00 PM ET)
Today's Range
Now: $0.04
50-Day Range
MA: $0.05
52-Week Range
Now: $0.04
Volume238,625 shs
Average Volume311,576 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Parallax Health Sciences, Inc. builds and expands an integrated digital healthcare network with products and services that can provide remote communication, diagnosis, treatment, and monitoring of patients on a proprietary platform. The company offers remote healthcare products, including patent pending software and mobile apps, and other services, as well as electronic kits and devices from third-party licensed platforms that are designated towards a patient's primary health concern, such as diabetes, blood pressure, cardiovascular, general monitoring, etc.; and audio and video options that interface with the patient's healthcare providers. It also provides prescription medication dosage monitoring services; and behavioral health products comprising REBOOT, a proprietary behavioral health technology for an individual or an organization to transform the cost of treating and managing chronic illnesses that include pulmonary-COPD-asthma, diabetes, and cardiovascular diseases by effecting the modification of behavior in patients being treated for these chronic diseases. In addition, the company offers diagnostics products, which comprise Target System, a proprietary POC diagnostic immunoassay testing platform; and test cartridges for the areas of infectious diseases, cardiac markers, drugs of abuse, and various other medical conditions, as well as VT-1000 desktop analyzers, target antigen detection systems, and other products. Further, it provides SPARKS Mobile, a target system hand-held analyzer; COMPASS for behavioral modification; Fotodigm platform for remote patient monitoring, telehealth, and POC diagnostic testing services; and Intrinsic Code technology for actionable insights to behavior modification. The company was formerly known as Endeavor Power Corporation and changed its name to Parallax Health Sciences, Inc. in January 2014. Parallax Health Sciences, Inc. was incorporated in 2005 and is headquartered in Santa Monica, California.

Industry, Sector and Symbol

Industry Diagnostics & Research
Current SymbolOTCMKTS:PRLX



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive PRLX News and Ratings via Email

Sign-up to receive the latest news and ratings for PRLX and its competitors with MarketBeat's FREE daily newsletter.

Parallax Health Sciences (OTCMKTS:PRLX) Frequently Asked Questions

What is Parallax Health Sciences' stock symbol?

Parallax Health Sciences trades on the OTCMKTS under the ticker symbol "PRLX."

Has Parallax Health Sciences been receiving favorable news coverage?

News headlines about PRLX stock have been trending very positive this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Parallax Health Sciences earned a media sentiment score of 3.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Parallax Health Sciences.

Who are some of Parallax Health Sciences' key competitors?

What other stocks do shareholders of Parallax Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Parallax Health Sciences investors own include Achillion Pharmaceuticals (ACHN), Akorn (AKRX), Activision Blizzard (ATVI), Broadcom (AVGO), Baidu (BIDU), Catalyst Biosciences (CBIO), Celsion (CLSN), Docusign (DOCU), Tilray (TLRY) and Aphria (APHA).

Who are Parallax Health Sciences' key executives?

Parallax Health Sciences' management team includes the folowing people:
  • Ms. Calli R. Bucci, CFO, Principal Accounting Officer, Corp. Sec. & Director (Age 54)
  • Dr. David Stark, Chief Regulatory Officer
  • Mr. Paul R. Arena, CEO, Pres & Director (Age 57)
  • Mr. Nathaniel T. Bradley, CTO & Director (Age 42)

How do I buy shares of Parallax Health Sciences?

Shares of PRLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Parallax Health Sciences' stock price today?

One share of PRLX stock can currently be purchased for approximately $0.04.

What is Parallax Health Sciences' official website?

The official website for Parallax Health Sciences is http://www.parallaxhealthsciences.com/.

How can I contact Parallax Health Sciences?

Parallax Health Sciences' mailing address is 1327 Ocean Ave Ste M, SANTA MONICA, CA 90401-1033, United States. The company can be reached via phone at +1-310-8994442.

MarketBeat Community Rating for Parallax Health Sciences (OTCMKTS PRLX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  36 (Vote Underperform)
Total Votes:  78
MarketBeat's community ratings are surveys of what our community members think about Parallax Health Sciences and other stocks. Vote "Outperform" if you believe PRLX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRLX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel